Can anticytokine therapy prevent unfavourable course of ulcerative colitis?
Aim of investigation. To study potential of tumor necrosis factor-alpha inhibitor Remicade to prevent complications and unfavorable course of ulcerative colitis.Material and methods. Therapeutic role of Remicade was investigated in one of three compared groups (24 patients) with unfavourable prognos...
Saved in:
Main Authors: | A. Yu. Baranovsky, E. A. Kondrashina, A. G. Kharitonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2013-12-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1251 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
by: A. Yu. Baranovsky, et al.
Published: (2012-06-01) -
Application of morphological criteria for definition of management approach for child with ulcerative colitis
by: E. N. Fedulova, et al.
Published: (2012-07-01) -
Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01) -
Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis
by: Fadhel A. Abdullah, et al.
Published: (2024-12-01) -
Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres
by: David Young, et al.
Published: (2025-01-01)